Biomanufacturing Viral Detection and Quantification Market Future Trends and Scope Analysis Report

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Biomanufacturing Viral Detection and Quantification Market Size, Share & Trends Analysis Report By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, and Others), By Application (Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing), By End User (Life Science Companies, Testing Laboratories, CROs and CDMOs) Market Outlook And Industry Analysis 2031".

The Biomanufacturing Viral Detection and Quantification Market Size is valued at 466.52 Million in 2022 and is predicted to reach 981.41 Million by the year 2031 at a 8.8% CAGR during the forecast period for 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1918

Viral detection and quantification play an essential role in biomanufacturing, particularly when viruses are active ingredients. Biomanufacturing viral detection and quantification is a process of analyzing and determining the amount or concentration of viruses in the context of large-scale production of biological materials such as vaccines, therapeutic proteins or viral vectors. It ensures the consistency, quality and safety of the final product. Methods used to detect and quantify viral contamination will vary depending on the specific requirements of the biomanufacturing process.

Various biological therapies carry a risk of bacterial, fungal and viral infection. Early detection of these contaminants is important to avoid production delays that can directly affect the healthcare industry. Hence, manufacturers use viral detection and quantification during biomanufacturing to evaluate & improve biomanufacturing, reduce contamination risk, and increase process efficiency.
The need for precise viral testing in the biomanufacturing of therapies is increasing, which is expected to boost the growth of the biomanufacturing viral detection and quantification market in the next few years.

Some of the prominent players in the Biomanufacturing Viral Detection and Quantification Market are:
• Danaher Corporation
• Merck KGaA
• New England Biolabs
• TAKARA HOLDINGS INC.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Promega Corporation
• QIAGEN N.V.
• Genscript Biotech Corporation
• Norgen Biotek Corp.
• Other Prominent Players

Biomanufacturing Viral Detection and Quantification Market Report Scope
Report Attribute Specifications
Market Size Value In 2022 USD 466.52 Million
Revenue Forecast In 2031 USD 981.41 Million
Growth Rate CAGR CAGR of 8.8 % from 2023 to 2031
Quantitative Units Representation of revenue in US$ Million and CAGR from 2023 to 2031
Historic Year 2019 to 2022
Forecast Year 2023-2031

Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Offering Type, Technology, Application,

End User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1918

Competitive Landscape Danaher Corporation, Merck KGaA, New England Biolabs, TAKARA HOLDINGS INC., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Genscript Biotech Corporation, Norgen Biotek Corp., and others.

Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Market Dynamics:
Drivers:

The factors responsible for driving the biomanufacturing viral detection and quantification market include the rapidly emerging technologies to enhance the detection & quantification of viral contaminants, increasing utilization of biopharmaceuticals, the need for stringent QC measures, and the advancements in viral testing technologies.

Increasing usage of biopharmaceuticals:
The quality of biopharmaceutical products is ensured through viral detection and quantification, which is essential to biopharmaceutical industries. QC (Quality Control) measures are necessary to maintain the safety, efficacy and consistency of biopharmaceuticals. Thus, the demand for viral testing technologies is increasing, surging the growth opportunities for the biomanufacturing viral detection and quantification market.

Advancements in viral testing technologies:
The development of assays such as polymerase chain reaction (PCR) and real-time PCR (qPCR) allows rapid and accurate virus detection by measuring the nucleic acid of the virus with certain accuracy and sensitivity.

Challenges:
However, expensive advanced viral detection and quantification instruments and the lack of skilled workers for implementation and analysis are predicted to hamper the market expansion during the forecast period.

Regional Trends:
The biomanufacturing viral detection and quantification market is growing rapidly, and North America is expected to capture the maximum share of the biomanufacturing viral detection and quantification market over the forecast period. The market's growth is mainly driven by increased demand for biological therapies, advancements in contaminant testing technologies, and rising government investments to improve the biomanufacturing process of the companies. Additionally, the Asia Pacific market will grow fastest over the projected period. Factors contributing to this growth are rising biopharma companies, well-established industrial infrastructure, government efforts for improving product quality, increasing innovations in cell & gene therapies, and the improved developmental capabilities of the contract manufacturing companies in this region.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1918

Key Developments In The Market:
• In September 2019, Merck KGaA partnered with Pfizer Inc. and launched a new drug BAVENCIO for t[the removal of viruses.
• In July 2018, Diversigen Inc. and Norgen Biotek Corp. entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses.
• In July 2016, Sartorius acquired ViroCyt for $16 million to expand the buyer's lab products and services offerings by adding the developer of rapid virus quantification tools. The deal is Sartorius' second tools acquisition in less than 3 weeks. On June 28, Sartorius signaled its expansion into bioanalytics by purchasing cell screening platforms developer IntelliCyt for $90 million.

Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Offering Type
• Consumables
• Instruments
• Services
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology
• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application
• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End User
• Life Science Companies
• Testing Laboratories
• CROs and CDMOs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Biomanufacturing Viral Detection and Quantification Market Revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Biomanufacturing Viral Detection and Quantification Market
 To receive an industry overview and future trends in the global Biomanufacturing Viral Detection and Quantification Market
 To analyze the Biomanufacturing Viral Detection and Quantification Market drivers and challenges
 To get information on the Biomanufacturing Viral Detection and Quantification Market size value (US$ Mn) forecast till 2031
 Major Investments, Mergers & Acquisitions in the global Biomanufacturing Viral Detection and Quantification Market industry

For More Infomation: https://www.insightaceanalytic.com/report/biomanufacturing-viral-detection-and-quantification-market/1918

Other Related Reports Published by InsightAce Analytic:
https://www.insightaceanalytic.com/report/cell-and-gene-therapy-bio-manufacturing-market/1692
https://www.insightaceanalytic.com/report/global-next-generation-biomanufacturing-market-/1261
https://www.insightaceanalytic.com/report/global-viral-and-non-viral-vector-manufacturing-market/1263

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

This release was published on openPR.